AMLYCAS

EUIPO EUIPO 2017 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark AMLYCAS was filed as Word mark on 10/13/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/30/2018. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 27, 2024

Trademark form Word mark
File reference 017326174
Application date October 13, 2017
Publication date October 23, 2017
Entry date January 30, 2018
Expiration date October 13, 2027

Trademark owner

Upper George's Street, Adelphi Plaza
Dun Laoghaire
IE

Trademark representatives

Gedempt Hamerkanaal 257 1021 KP Amsterdam NL

goods and services

5 Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes

Trademark history

Date Document number Area Entry
February 26, 2024 Change Representative, Published
January 7, 2021 Change Representative, Published
January 5, 2021 Change Representative, Published
July 9, 2018 Transfer / Change of address, Published
June 22, 2018 Registration, Published

ID: 11017326174